RA
TECH icon

Rise Advisors’s Bio-Techne TECH Stock Holding History

Rise Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-181
Closed -$10.1K – 1283
2025
Q3 		$10.1K Hold
181
– – ﹤0.01% 993
2025
Q2 		$9.3K Buy
181
+1
+0.6% +$50 ﹤0.01% 1031
2025
Q1 		$10.6K Sell
180
-29
-14% -$1.97K ﹤0.01% 928
2024
Q4 		$15.1K Hold
209
– – 0.01% 826
2024
Q3 		$16.7K Hold
209
– – 0.01% 805
2024
Q2 		$15K Hold
209
– – 0.01% 828
2024
Q1 		$14.7K Buy
+209
New +$15K 0.01% 869
2023
Q4 		– Sell
-1
Closed -$64 – 667
2023
Q3 		$64 Sell
1
-140
-99% -$11.1K ﹤0.01% 633
2023
Q2 		$11.5K Hold
141
– – 0.01% 321
2023
Q1 		$10.4K Hold
141
– – 0.01% 355
2022
Q4 		$11.6K Buy
141
+1
+0.7% +$79 0.01% 330
2022
Q3 		$10K Hold
140
– – 0.01% 344
2022
Q2 		$12K Buy
+140
New +$13.1K 0.01% 318

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rise Advisors's TECH Position: Q4 2025 in Review

Rise Advisors sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 181 shares — an estimated $10.1K sold.

Rise Advisors first reported a position in TECH in Q2 2022 and held it in 13 quarters. The position peaked at $16.7K in Q3 2024. 586 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Rise Advisors reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 181 Bio-Techne shares in Q4 2025, an estimated $10.1K.
  • Rise Advisors first reported a position in Bio-Techne in Q2 2022 and held it in 13 quarters.
  • Rise Advisors's Bio-Techne position peaked at $16.7K in Q3 2024.
  • 586 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.